Squarepoint
PBLA

Squarepoint’s Panbela Therapeutics, Inc. Common Stock PBLA Stock Holding History

Squarepoint’s Portfolio PBLA Stock Details PBLA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-1
Closed -$61K – 3943
2021
Q1 		$61K Buy
+1
New +$113K ﹤0.01% 2975

Other funds holding PBLA

IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
M
Murchinson Toronto, Ontario, Canada $791M AUM 68.08% 1-Year Est. Return
FPS
Fieldpoint Private Securities Greenwich, Connecticut $344M AUM 7.21% 1-Year Est. Return
BAMG
Brand Asset Management Group Chesterfield, Missouri $385M AUM 22.41% 1-Year Est. Return
CH
CVI Holdings Wilmington, Delaware $116M AUM 5.68% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return
NAM
NewGen Asset Management Toronto, Ontario, Canada $259M AUM 140.76% 1-Year Est. Return
BSW
Buckingham Strategic Wealth Clayton, Missouri $9.66B AUM 15.76% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Squarepoint's PBLA Position: Q2 2021 in Review

Squarepoint sold out of Panbela Therapeutics, Inc. Common Stock (PBLA) in Q2 2021, closing a stake of 1 share — an estimated $61K sold.

Squarepoint first reported a position in PBLA in Q1 2021 and held it in 1 quarter. The position peaked at $61K in Q1 2021. 11 funds tracked by Wall St. Rank hold PBLA as of Q2 2021.

  • Squarepoint reported no remaining Panbela Therapeutics, Inc. Common Stock position as of Q2 2021 after selling out during the quarter.
  • Squarepoint sold 1 Panbela Therapeutics, Inc. Common Stock share in Q2 2021, an estimated $61K.
  • Squarepoint first reported a position in Panbela Therapeutics, Inc. Common Stock in Q1 2021 and held it in 1 quarter.
  • Squarepoint's Panbela Therapeutics, Inc. Common Stock position peaked at $61K in Q1 2021.
  • 11 funds tracked by Wall St. Rank held Panbela Therapeutics, Inc. Common Stock as of Q2 2021.

Based on Squarepoint's 13F filing for Q2 2021, filed 16 Aug 2021.